The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids
Journal of Virology · 31.01.2025 · 99 (1)
DOI: 10.1128/jvi.01853-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, erschienen am 31.01.2025. Verfasst von Masatoshi Kakizaki und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan. Hauptthemen laut MEDLINE: Serine Endopeptidases, Organoids, SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED), Astellas Foundation for Research on Metabolic Disorders, MEXT | Japan Society for the Promotion of Science (JSPS).
Abstract (Originalsprache)
A critical aspect of the mechanism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is the protease-mediated activation of the viral spike (S) protein. The type II transmembrane serine protease TMPRSS2 is crucial for SARS-CoV-2 infection in lung epithelial Calu-3 cells and murine airways. However, the importance of TMPRSS2 needs to be re-examined because the ability to utilize TMPRSS2 is significantly reduced in the Omicron variants that spread globally. For this purpose, replication profiles of SARS-CoV-2 were analyzed in human respiratory organoids. All tested viruses, including Omicron variants, replicated efficiently in these organoids. Notably, all SARS-CoV-2 strains retained replication ability in TMPRSS2-gene knockout (KO) respiratory organoids, suggesting that TMPRSS2 is not essential for SARS-CoV-2 infection in human respiratory tissues. However, TMPRSS2-gene knockout significantly reduces the inhibitory effect of nafamostat, indicating the advantage of TMPRSS2-utilizing ability for the SARS-CoV-2 infection in these organoids. Interestingly, Omicron variants regained the TMPRSS2-utilizing ability in recent subvariants. The basal infectivity would be supported mainly by cathepsins because the cathepsin inhibitor, EST, showed a significant inhibitory effect on infection with any SARS-CoV-2 strains, mainly when used with nafamostat. A supplementary contribution of other serine proteases was also suggested because the infection of the Delta variant was still inhibited partially by nafamostat in TMPRSS2 KO organoids. Thus, various proteases, including TMPRSS2, other serine proteases, and cathepsins, co-operatively contribute to SARS-CoV-2 infection significantly in the respiratory organoids. Thus, SARS-CoV-2 infection in the human respiratory tissues would be more complex than observed in cell lines or mice. IMPORTANCE We explored how the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus infects human respiratory organoids, which are a cultured cell model made to mimic the physiological conditions of the human airways. We focused on understanding the role of different proteases of host cells in activating the virus spike proteins. Specifically, we looked at TMPRSS2, a transmembrane serine protease, and cathepsin L, a lysosomal enzyme, which helps the virus enter cells by cutting the viral spike protein. We discovered that while TMPRSS2 is crucial for the virus in certain cells and animal models, other proteases, including cathepsins and various serine proteases, also play significant roles in the SARS-CoV-2 infection of human respiratory organoids. We suggest that SARS-CoV-2 uses a more complex mechanism involving multiple proteases to infect human airways, differing from what we see in conventional cell lines or animal models. This complexity might help explain how different variants can spread and infect people effectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
- Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
- Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
- Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Kyoto, Japan.
- Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.
- Department of Microbiology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Noriyo Nagata, Kazuya Shirato, Kazuo Takayama, Makoto Takeda
Förderung
- Japan Agency for Medical Research and Development (AMED)
- Astellas Foundation for Research on Metabolic Disorders
- MEXT | Japan Society for the Promotion of Science (JSPS)
- Shionogi Infectious Disease Research Promotion Foundation
- The Mitsubishi Foundation
- The Chemo-Sero-Therapeutic Research Institute
Zitieren
APA
Kakizaki, M., Hashimoto, R., Nagata, N., Yamamoto, T., Okura, T., Katoh, H., Kitai, Y., Akahori, Y., Shirato, K., Ryo, A., Takayama, K., & Takeda, M. (2025). The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids. Journal of Virology, 99(1). https://doi.org/10.1128/jvi.01853-24
Vancouver
Kakizaki M, Hashimoto R, Nagata N, Yamamoto T, Okura T, Katoh H, et al. The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids. Journal of Virology. 2025;99(1). doi:10.1128/jvi.01853-24
BibTeX
@article{Kakizaki2025,
author = {Kakizaki, Masatoshi and Hashimoto, Rina and Nagata, Noriyo and Yamamoto, Takuya and Okura, Takashi and Katoh, Hiroshi and Kitai, Yuki and Akahori, Yukiko and Shirato, Kazuya and Ryo, Akihide and Takayama, Kazuo and Takeda, Makoto},
title = {The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids},
journal = {Journal of Virology},
year = {2025},
volume = {99},
number = {1},
doi = {10.1128/jvi.01853-24}
}
EUVIMED